EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design and Characterization of Novel Gastroretentive Drug Delivery System of Antibiotics and Piperine for the Eradication of H. pylori Infection

Ashutosh Gupta, Moumita Saha, Shivani Shailesh Kunkalienkar iD, Aadarsh Ghurye, Shweta Verma, Jahnavy Joshi, Abhishek Jha, Srinivas Mutalik iD, Shiran Shetty, Raghu Chandrashekar Hariharapura, Ashwini Aithal, K Nandakumar iD und 2 weitere

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c01253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Ashutosh Gupta und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 5…. Hauptthemen laut MEDLINE: Alkaloids, Piperidines, Polyunsaturated Alkamides, Helicobacter pylori. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori (H. pylori) infection affects about half the world population, and if left untreated, can cause painful sores in the stomach lining and intestinal bleeding, leading to peptic ulcer disease (PUD) and stomach cancer. Treatment of H. pylori infection is always a challenge to the treating doctor because of the treatment inefficiency resulting from the poor bioavailability of the drug at the inner layers of the gastric mucosa, where the bacteria reside. This also results in the development of antibiotic resistance. In this work, we developed a mucoadhesive gastroretentive drug delivery system (M-GRDDS) for the effective delivery of antibiotics and piperine to the gastric mucosa. The GRDDS system was formulated by using the ion-gelation method and was evaluated for its entrapment efficiency, particle size, swelling behavior, drug release, mucoadhesion property, and H. pylori eradication efficacy. The efficacy of the drug-loaded mucoadhesive GRDDS formulation was compared with that of the free drug. Results showed that the percentage entrapment efficiency was more than 80% for all the drugs. M-GRDDS beads showed controlled release at pH 1.2 and 7.4. The optimized mucoadhesive beads showed good in vitro mucoadhesion in X-ray photography, with a mean gastric residence time of more than 8 h in rabbits. Tissue distribution study in rats revealed local delivery of the drugs to the gastric mucosa from the M-GRDDS beads. The in vivo efficacy study performed on Sprague-Dawley rats showed that the colony-forming units in the group treated with the novel GRDDS formulation were fewer than those in the group treated with the free drugs. Biochemical tests, gene expression studies, and histopathology studies corroborated the enhanced efficacy of the M-GRDDS formulation in eradicating the infection and curing peptic ulcers. The results conclude that the developed M-GRDDS formulation holds significant potential for improving local bioavailability, contributing to the more effective eradication of H. pylori-based gastric ulcers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkaloidsPiperidinesPolyunsaturated AlkamidesHelicobacter pyloriHelicobacter InfectionsBenzodioxolesAnti-Bacterial AgentsDrug Delivery SystemsAnimalsGastric MucosaDrug LiberationRatsMaleParticle SizeRats, Sprague-DawleyRabbits

Stichwörter der Autor:innen

Helicobacter pyloriantibacterial effectantibioticsgastric ulcergastroretentive drug delivery system

Substanzen

AlkaloidsPiperidinespiperinePolyunsaturated AlkamidesBenzodioxolesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
  • Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
  • Manipal Centre for Biotherapeutics Research, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
  • Department of Pharmaceutics, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research Pimpri, Pune 411018, India.
  • Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
  • Department of Gastroenterology and Hepatology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.

ORCID-Profile: Shivani Shailesh Kunkalienkar, Srinivas Mutalik, K Nandakumar, Sudheer Moorkoth

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Gupta, A., Saha, M., Kunkalienkar, S. S., Ghurye, A., Verma, S., Joshi, J., Jha, A., Mutalik, S., Shetty, S., Hariharapura, R. C., Aithal, A., Nandakumar, K., Seetharam, R. N., & Moorkoth, S. (2025). Design and Characterization of Novel Gastroretentive Drug Delivery System of Antibiotics and Piperine for the Eradication of H. pylori Infection. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01253

Vancouver

Gupta A, Saha M, Kunkalienkar SS, Ghurye A, Verma S, Joshi J, et al. Design and Characterization of Novel Gastroretentive Drug Delivery System of Antibiotics and Piperine for the Eradication of H. pylori Infection. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01253

BibTeX
@article{Gupta2025,
  author = {Gupta, Ashutosh and Saha, Moumita and Kunkalienkar, Shivani Shailesh and Ghurye, Aadarsh and Verma, Shweta and Joshi, Jahnavy and Jha, Abhishek and Mutalik, Srinivas and Shetty, Shiran and Hariharapura, Raghu Chandrashekar and Aithal, Ashwini and Nandakumar, K and Seetharam, Raviraja N and Moorkoth, Sudheer},
  title = {Design and Characterization of Novel Gastroretentive Drug Delivery System of Antibiotics and Piperine for the Eradication of H. pylori Infection},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c01253}
}
Kostenlos starten →